Clinical Trials Browser

INDUSTRY × trebananib × Tumor-Agnostic × Clear all

NCT02525536 2015-09-22

A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of Trebananib (AMG 386 ) in Adult Japanese Participants With Advanced Solid Tumors

Phase 1 Completed

18 enrolled 38 charts

Neoplasms

NCT00102830 2010-08-20

Study Evaluating AMG 386 in Adult Patients With Advanced Solid Tumors

Phase 1 Completed

Neoplasm Metastasis, Neoplasms